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BRIEF DEFINITIVE REPORT
 Infl ammation is a component of many vascular 
disorders such as aortic aneurysm, giant cell ar-
teritis, Takayasu ’ s disease, and atherosclerosis 
( 1 – 4 ). DCs carry out many innate responses and 
orchestrate adaptive immunity ( 5 ). It is there-
fore important to assess the presence and prop-
erties of DCs in major blood vessels. 
 Initially, electron microscopy and labeling 
for several intracellular markers were used to 
demonstrate DCs in human aorta, primarily in 
a subendothelial location ( 6 – 9 ). Ma-Krupa et al. 
( 10 ) and Pryshchep et al. ( 11 ) then used more 
cell-restricted markers to identify DCs in in-
creased numbers in human arteries, whereas 
Bobryshev ( 12 ) reported increased numbers of 
cells expressing S100, CD1a, and p55 markers 
in the intima and adventitia during atheroscle-
rosis. Cells bearing the CD11c integrin, which 
is characteristically expressed at high levels on 
DCs, were also identifi ed in the normal aortic 
intima and in atherosclerosis-prone areas in 
mice ( 13, 14 ). The numbers of aortic CD11c + 
cells increased with aging and atherosclero-
sis through a recruitment process involving 
CX3CR1 chemokine receptor and VCAM-1 
( 13, 15, 16 ). 
 Although abundant CD11c expression is a 
well-known marker for DCs, other cell types can 
express moderate levels of CD11c, including ac-
tivated NK cells, some macrophages, and even 
some T cells ( 17 – 21 ). Therefore, additional crite-
ria are required to identify DCs in the vascular 
wall in the steady state and ultimately disease, par-
ticularly the capacity of DCs to express MHC 
class II and present antigens to T lymphocytes. 
 In this study, we found that the CD11c pro-
moter – enhanced yellow fl uorescent protein 
(EYFP) transgenic mouse developed by Lindquist 
et al. ( 22 ) is valuable to identify and study CD11c + 
cells from the normal mouse aorta. We will report 
on the location, cell surface markers, and antigen-
presenting functions of DCs and also describe 
their abundance in all of the cardiac valves. 
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 Presumptive dendritic cells (DCs) bearing the CD11c integrin and other markers have 
previously been identifi ed in normal mouse and human aorta. We used CD11c promoter –
 enhanced yellow fl uorescent protein (EYFP) transgenic mice to visualize aortic DCs and study 
their antigen-presenting capacity. Stellate EYFP + cells were readily identifi ed in the aorta 
and could be double labeled with antibodies to CD11c and antigen-presenting major histo-
compatability complex (MHC) II products. The DCs proved to be particularly abundant in 
the cardiac valves and aortic sinus. In all aortic locations, the CD11c + cells localized to the 
subintimal space with occasional processes probing the vascular lumen. Aortic DCs ex-
pressed little CD40 but expressed low levels of CD1d, CD80, and CD86. In studies of anti-
gen presentation, DCs selected on the basis of EYFP expression or binding of anti-CD11c 
antibody were as effective as DCs similarly selected from the spleen. In particular, the 
aortic DCs could cross-present two different protein antigens on MHC class I to CD8 + TCR 
transgenic T cells. In addition, after intravenous injection, aortic DCs could capture anti-
CD11c antibody and cross-present ovalbumin to T cells. These results indicate that bona 
fi de DCs are a constituent of the normal aorta and cardiac valves. 
© 2009 Choi et al. This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the fi rst six months after the pub-
lication date (see http://www.jem.org/misc/terms.shtml). After six months it is avail-
able under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 
Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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 Aortic DCs are mainly localized in the subintimal space 
 To examine the position of the EYFP + DCs in the aortic wall, 
we performed confocal microscopy with simultaneous staining 
for CD31 to mark the vascular endothelium ( 26 ). In addition, 
the confocal images were reconstituted into three-dimensional 
images using the Imaris program to gain better understanding 
of the anatomical localization of aortic DCs. The DCs were 
 RESULTS AND DISCUSSION 
 Aortic DCs are readily visualized in CD11c-EYFP 
transgenic mice 
 The CD11c-EYFP transgenic mouse (C57BL/6 background), 
in which expression of the EYFP gene is controlled by the 
CD11c promoter, was developed to better visualize and char-
acterize DCs in situ, beginning with lymphoid organs in the 
steady state ( 22 ). We performed fl ow cytometry on aortic cell 
suspensions and found that 0.25 – 0.5% of the cells expressed 
EYFP, with the signal ranging from low to high ( Fig. 1 A ). 
The isolated EYFP + cells also could be stained for cell surface 
CD11c and MHC class II ( Fig. 1 B , top). If we isolated 
CD11c + cells from normal nontransgenic C57BL/6 mice, we 
again saw clear labeling for MHC class II ( Fig. 1 B , bottom), 
but the signals with anti-CD11c were much weaker than those 
observed with EYFP mice. When we examined whole mounts 
of the aorta, brightly EYFP + dendritic profi les were evident, 
and these could be double labeled with antibodies to CD11c 
and MHC class II ( Fig. 1 C ), two markers of typical DCs in 
the steady state. However this staining required the use of 
tyramide amplifi cation (see Materials and methods). These 
results indicate that the CD11c-EYFP transgenic mouse is 
valuable to identify and visualize aortic DCs in cell suspensions 
and in situ. 
 Aortic DCs are abundant in the aortic valve and sinus 
 To examine the distribution of DCs in the aorta, we examined 
sheet preparations by confocal microscopy. In accordance with 
previous reports ( 13, 15 ), we found that the EYFP + DCs were 
primarily in the intima and in focal accumulations, i.e., in the 
lesser curvature of the aortic arch and the openings of arteries, 
rather than a scattered distribution in the adventitia ( Fig. 2 A ). 
 When we turned to the root of the aorta, as diagrammed in 
 Fig. 2 B , large numbers of DCs were found in the aortic valve 
and sinus ( Fig. 2 C ). We then prepared cell suspensions from the 
aortic valve and sinus and compared the yield of DCs relative to 
suspensions from the aortic arch and descending aorta. The aor-
tic root, i.e., valve and sinus, suspensions had more numerous 
EYFP cells ( Fig. 2 D , top), confi rming the observations in intact 
tissue ( Fig. 2 C ). Likewise when we studied nontransgenic 
C57BL/6 mice and stained cell suspensions with anti-CD11c 
antibody, the aortic root had more abundant DCs, although the 
intensity of the anti-CD11c signal was much reduced relative to 
the EYFP signal in transgenic mice ( Fig. 2 D ). Mean values for 
three experiments are shown in  Fig. 2 D (bottom). 
 The presence of DCs in normal aortic valve prompted us to 
examine other normal cardiac valves. Accumulations of DCs 
have been reported in valves in degenerative disease, bioprosthe-
ses, and papillary fi broelastomas ( 23, 24 ). In a single prior study 
of normal aortic valves, fresh and cryopreserved tissue had no 
DCs ( 25 ). However, we observed many EYFP + DCs in the left 
(mitral) and right (tricuspid) atrioventricular valves ( Fig. 2 E ). 
These fi ndings with CD11c-EYFP mice extend prior studies by 
showing that aortic DCs are especially abundant in the root of 
the aorta and all cardiac valves. 
 Figure 1.  Visualizing aortic DCs using CD11c-EYFP transgenic 
mice. (A) The presence of EYFP + cells in aortic cell suspension from EYFP 
transgenic mice. Aortic segments from EYFP transgenic mice ( n = 5) were 
pooled and dissociated by incubation with an enzyme mixture (see 
Materials and methods) and then subjected to fl ow cytometric analysis. 
(B) Experiments were performed as in A, but the aortic CD11c + cells were 
from nontransgenic mice ( n = 3) and compared for expression of CD11c 
and MHC II to aortic EYFP + cells. (C) Immunohistochemical staining of 
CD11c and MHC II in aortic sheets. Each experiment was performed at 
least three times. Bars, 20  μ m. 
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 In previous studies, it has been shown that intestinal DCs 
extend their dendritic processes across the epithelium to cap-
ture bacteria in lumen ( 27 ). To determine whether aortic 
DCs could extend processes into the vessel lumen and capture 
proteins, we applied anti-CD11c antibody to whole segments 
of aorta from CD11c-EYFP mice, i.e., without tissue perme-
abilization using Triton X-100. Parts of some of the DCs 
were stained with anti-CD11c antibody ( Fig. 3 C ). Next, we 
injected anti-CD11c antibody i.v. to CD11c-EYFP mice and 
localized beneath the endothelium ( Fig. 3, A and B ; and 
Video 1, available at http://www.jem.org/cgi/content/full/jem
.20082129/DC1), although infrequently in the aortic sinus, 
dendritic processes penetrated between endothelial cells into 
the lumen ( Fig. 3 A , middle, arrow; and Video 2). In all sites, 
i.e., aortic root, aortic arch, and descending aorta, the bodies 
of the CD11c + DCs were located in the subintimal space, and 
most of the dendritic processes extended laterally within the 
subintimal areas ( Fig. 3, A and B , red). 
 Figure 2.  Predominant localization of aortic DCs in the aortic valve and sinus. Aortic segments from aortic sinus to diaphragm were opened lon-
gitudinally to make aortic sheets. The distribution of aortic DCs was analyzed using confocal microscopy. (A) EYFP + DCs in the intima of the aortic arch 
(top left) and openings of arterial branches (top right). Adventitial EYFP + DCs were scattered throughout the aorta including aortic arch (bottom left) and 
descending aorta (bottom right) (B) Diagram of aortic sinus. Red indicates DC-abundant areas. (C) EYFP + DCs in aortic valve (left) and sinus (right). 
(D) Flow cytometric analysis of EYFP + cells. The mean and SD of three experiments are shown below, with the aortic cell suspension in each experiment 
being from at least three mice. (E) The presence of DCs in normal cardiac valves including left (left panel) and right (right panel) atrioventricular valves. 
The cardiac valves were isolated using microscissors under guidance of a dissecting microscope. The valvular sheets were mounted on glass slides and 
observed by confocal microscopy. Each fi gure is representative of at least three experiments. Bars, 40  μ m. 
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 Figure 3.  The anatomical position of aortic DCs in aortic wall . After immunostaining the aortic sheet using CD31 antibody to visualize the endo-
thelium, confocal images were taken along the Z axis to visualize all dendritic processes from each EYFP + DC and were reconstituted to a Z stack. 
(A) Reconstituted Z planes from aortic valve (top), aortic sinus (middle), and aortic arch (bottom) show that the aortic DCs are localized beneath the endo-
thelium. A small number of DCs in the aortic sinus extend their processes into the vessel lumen (A, middle, arrow). (B) Three-dimensional images were 
reconstituted using the Imaris program to better visualize the position of aortic DCs. Arrows indicate the vessel lumen side. (C) Exposure of some den-
dritic processes into the lumen. The aortic sheets from EYFP transgenic mice were stained with CD11c antibody without tissue permeabilization to see 
whether dendritic processes could capture antibody from the lumen. The confocal images were reconstituted in three dimensions. (D) Biotinylated anti-
CD11c and hamster IgG control antibody were injected i.v. to CD11c-EYFP mice. After 3 h, the aortic segments were isolated, incubated with horseradish 
peroxidase – conjugated streptavidin, and the stained CD11c was enhanced with Alexa Fluor 555 tyramide. (E) The elastic lamina was visualized using its 
autofl uorescence. The confocal images were reconstituted in three dimensions. Each fi gure is representative of at least three experiments. Bars, 20  μ m. 
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evident from Fig. S2 A (available at http://www.jem.org/cgi/
content/full/jem.20082129/DC1), splenic DCs presented 
OVA protein at relatively low doses (60 – 200  μ g/ml) to OT-I 
transgenic T cells. In contrast, when we studied presentation of 
the mouse malaria circumsporozoite (CS) protein (CSP) to 
CSP-specifi c CD8 + TCR transgenic T cells (YA26), higher 
concentrations of protein were required than with the OVA-
specifi c OT-I T cells (Fig. S2 B). Likewise, when we used spe-
cifi c peptide as antigen, the OT-1 transgenic T cells were at 
least 100 times more sensitive than YA26 T cells to antigen in 
the presence of DCs. All OT-1 cells entered cell cycle in re-
sponse to 1 pM of peptide, whereas YA26 T cells required 1 
nM ( Fig. 5 A ). With both TCR transgenic T cells, if the DCs 
were fi xed with formaldehyde before testing, presentation of 
protein antigen, but not preprocessed peptide, was ablated, in-
dicating that our protein preparations were not signifi cantly 
contaminated with active peptide (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20082129/DC1). We also 
assessed the importance of DC dose and time of culture for 
cross-presentation to CD8 + TCR transgenic T cells. A DC to 
T cell ratio of 1:6 induced proliferation (two to four cycles of 
division) in the culture within 3 – 4 d (Fig. S4). Therefore, OT-I 
cells are much more sensitive than a T cell clone specifi c for an 
important microbial protein and capable of mediating protec-
tive anti – mouse malaria immunity in vivo ( 28 ). 
 Using these assay conditions, we fi rst tested aortic CD11c + 
cells from normal C57BL/6 (B6) mice ( n = 6) isolated on 
CD11c MACS beads. However, the CD11c-enriched aortic 
cells only induced weak proliferation of OT-I and OT-II 
cells (unpublished data). When we enumerated DCs in cells 
isolated with MACS beads, the DC purity was  < 10%. To in-
crease the purity of aortic CD11c + cells, we used CD11c-
EYFP transgenic mice. After dissociating the aortic tissue 
from groups of 10 mice in each experiment, EYFP + cells 
were isolated by FACS sorting. From an 8-wk-old adult 
mouse, we typically isolated   1,500 EYFP + cells from one 
aortic segment, i.e., from aortic sinus to thoracic aorta inclu-
sive. When the isolated EYFP + cells were used to present 
OVA to OT-I and OT-II T cells, we observed strong prolif-
erative responses with most of the T cells entering cell cycle 
and undergoing several divisions in 4 or 5 d ( Fig. 5 B ). 
found that some of the DCs were stained by the injected anti-
body ( Fig. 3 D ), suggesting exposure of some aortic DC pro-
cesses to the contents of the lumen. 
 To investigate whether DC processes extend into the tu-
nica media, the aortic elastic lamina was visualized using its 
autofl uorescence. We found that the DC processes were an-
chored to the elastic lamina and rarely penetrated the internal 
elastic lamina ( Fig. 3 E and Video 3, available at http://www
.jem.org/cgi/content/full/jem.20082129/DC1). These ob-
servations indicate a primarily subendothelial location of aor-
tic DCs with some exposure to the blood stream. 
 Aortic and splenic DCs have similar but not 
identical phenotypes 
 To phenotype aortic DCs, we prepared cell suspensions from 
aorta and spleen of EYFP transgenic mice and double labeled 
for CD11c and various markers. Aortic DCs lacked CD40, 
but expressed low levels of CD1d, CD80, and CD86, indi-
cating their immature status ( Fig. 4 , top). Splenic EYFP + 
DCs had slightly higher amounts of CD1d, CD40, and CD80 
when compared with aortic DCs ( Fig. 4 , bottom). We also 
analyzed the phenotype of DCs from aorta and spleen of 
nontransgenic mice and assessed this same panel of markers. 
Again aortic and spleen DCs were similar in phenotype, 
with spleen DCs expressing more CD1d, CD40, and CD80, 
although still not in high amounts (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20082129/DC1). 
Together, these fi ndings indicate that aortic DCs are in an 
immature state with little or no expression of costimula-
tory molecules. 
 Aortic CD11c + DCs cross-present antigens 
on MHC class I products 
 Although there have been several morphological analyses of 
normal aortic CD11c + cells, there has been no functional evi-
dence to show that these cells can present antigens to T lym-
phocytes, including a property that is well developed in some 
DCs, which is cross-presentation of proteins on MHC class I to 
CD8 + T cells. To assess this, we fi rst worked out assay condi-
tions for antigen presentation using CD8 + TCR transgenic T 
cells as reporters for cross-presentation by splenic DCs. As is 
 Figure 4.  Comparison of cell surface markers of aortic and splenic DCs. Aortic and spleen cell suspensions from transgenic mice ( n = 5) was 
stained with antibodies to each surface marker as shown. Each fi gure is representative of at least three experiments. 
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 Figure 5.  Antigen presentation to T cells by aortic DCs. (A) Comparison between OT-1 and YA26 TCR transgenic CD8 + T cells. The indicated concen-
trations of OT-1 peptide (SIINFEKL) or CS peptide (SYVPSAEQI) were added to each T cell with or without splenic DCs. After 4 d, T cell proliferation was 
analyzed by CFSE dilution. (B) Presentation to OVA-specifi c TCR transgenic T cells. Aortic and splenic EYFP + and EYFP    cells were isolated from EYFP trans-
genic mice ( n = 10) by FACS sorting. CD8 + OT-I and CD4 + OT-II cells were isolated using Dynabeads. 200  μ g/ml OVA protein was added to the DC – T cell 
cocultures. Proliferation of OT-I and OT-II cells was evaluated by CFSE dilution on the FACS. The right shows the mean and SD of three experiments. 
(C) Presentation to YA26 T cells. Aortic and splenic CD11c high CD3    CD19    DX5    cells were isolated using FACS sorting and YA26 T cells with Dynabeads. 
500  μ g/ml CSP was added to the DC – T cell cocultures. Proliferation of CSP-specifi c TCR transgenic T cells was evaluated by CFSE dilution. The right shows 
the mean and SD of three experiments. (D) 5 mg OVA was injected i.v. to CD11c-EYFP ( n = 10) mice. After 20 h, the aortic cell suspensions were prepared 
and sorted to isolate EYFP + and EYFP    cells. Spleen EYFP + and EYFP    cells were also isolated from the mice. The cells were added to OT-1 T cells at ratio of 
1:3. After 3 d, T cell proliferation was analyzed by CFSE dilution. This result is representative of two independent experiments. 
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 Because the cross-presentation of OVA to OT-I transgenic 
T cells is a particularly sensitive system, we next examined an-
other CD8 + T cell, YA26. Because the CSP-specifi c CD8 + 
TCR transgenic mouse is H-2d restricted, we isolated aortic 
and splenic CD11c + cells from BALB/c or C × B6 F 1 mice by 
FACS sorting. In accordance with a previous study ( 13 ), the 
number of isolated DCs from these mice was   50% of that 
seen with C57BL/6 mice. Nonetheless, the CD11c + aortic 
cells could induce YA26 T cell proliferation with CSP, whereas 
CD11c    cells could not ( Fig. 5 C ).  Fig. 5 (B and C , right) 
shows means from three experiments using aortic DCs as ef-
fective antigen-presenting cells, including cross-presentation. 
 We next examined whether the aortic DCs could cross-
present blood-borne protein antigen to T cells. 5 mg OVA was 
injected i.v. and, after 20 h, the aortic EYFP + and EYFP    cells 
were isolated by FACS sorting. Splenic EYFP high and EYFP    
cells were also isolated in parallel. When the isolated DCs were 
mixed with OT-1 cells for 3 d, the EYFP + aortic DCs eff ectively 
induced the proliferation of OT-1 cells ( Fig. 5 D ), indicating that 
aortic DCs can take up and cross-present protein antigen from 
the blood stream. We were struck by the fi nding that aortic DCs 
seemed to capture and present OVA better than splenic DCs un-
der our experimental conditions. We suspect that i.v. OVA is 
not an optimal system to reveal the antigen capture and present-
ing activity of splenic DCs because OVA can be recognized by 
mannose receptors that are expressed on liver sinusoidal endo-
thelium ( 29, 30 ). If so, aortic DCs may have more ready access 
to the injected OVA. 
 The CD11c promoter-EYFP mouse has been valuable for 
visualizing DCs in situ, including lymphoid organs and lung 
( 22, 31 ). We now fi nd that the CD11c-EYFP transgenic 
mouse is valuable for identifying DCs in the aorta. The strong 
EYFP stain allows for their ready identifi cation in the subinti-
mal space of select regions of the aorta and in all the cardiac 
valves. Moreover, the EYFP fl uoresence can be used to isolate 
the DCs by cell sorting and to phenotype the cells to show that 
they express MHC II and other markers of immature DCs. 
 The aortic subendothelial space is an important site for the 
initiation of atherosclerosis because proatherogenic LDL parti-
cles can be generated in subendothelial spaces by enzymatic or 
nonenzymatic modifi cations during hyperlipidemia ( 32, 33 ). 
Our results that DCs are in subintimal space and capture pro-
teins from the blood stream suggest that these cells should also 
be considered in generating infl ammation and even immunity 
in atherosclerosis-prone areas. DCs, for example, might pres-
ent lipids to NKT cells leading to cytokine production and 
cytotoxicity ( 34 ), and DCs appear to have a specialized endo-
cytic system in which internalized substrates are not totally ca-
tabolized but, instead, peptides are salvaged for presentation to 
T cells ( 35 ). 
 Importantly, we verify that aortic CD11c + cells are eff ec-
tive antigen-presenting cells, as is characteristic of DCs. DCs 
capture invading pathogens to generate resistance to infection, 
and they contribute to immune tolerance, making these cells 
an important target in studying pathogenesis and prevention of 
disease ( 36 ). Aortic DCs are mainly localized in areas having 
turbulent fl ow including the aortic valve, sinus, lesser curva-
ture of the aortic arch, and openings of arterial branches. In 
this study, we fi nd that these DCs can eff ectively cross-present 
i.v.-injected OVA to T cells. Turbulent fl ow may allow DCs 
in the aorta and cardiac valves to capture disease-related patho-
gens and proteins and present these to T cells. 
 MATERIALS AND METHODS 
 Mice.  CD11c-EYFP transgenic mice were a gift of M.C. Nussenzweig, N. 
Anandasabapathy, and J. Idoyaga (The Rockefeller University, New York, NY). 
We used C57BL/6 (Taconic), BALB/c (Taconic), and C × B6 F 1 (Harlan) mice. 
Mice were maintained under specifi c pathogen-free conditions and fed a normal 
mouse diet ad libitum. Mouse protocols were approved by the Institutional Ani-
mal Care and Use Committee of The Rockefeller University. 
 Antibodies and reagents.  Antibodies to cell surface markers were CD11c, 
MHC II, CD31, CD80, CD86, CD1d, CD40, and CD11b (all obtained from 
BD). Dynabeads were obtained from Invitrogen. Biotinylated antibodies to 
CD11c and MHC class II were obtained from BD. The tyramide signal am-
plifi cation kit was obtained from Invitrogen. OVA protein was obtained from 
the Seikagaku Corporation. 
 Aortic single cell preparations and fl ow cytometric analysis.  Aortic 
single cells were prepared using previous methods with minor modifi cations 
( 16 ). In brief, after careful removal of the perivascular fat and cardiac muscle 
tissues, using microscissors under a dissecting microscope, single cell suspen-
sions from aortic segments, including aortic sinus with valve or aortic arch and 
thoracic aorta, were prepared by incubation with an enzyme mixture contain-
ing 450 U/ml collagenase I, 125 U/ml collagenase XI, 60 U/ml hyaluroni-
dase, and 60 U/ml DNase in modifi ed Dulbecco ’ s PBS with calcium and 
magnesium for 90 min at 37 ° C with gentle shaking. Splenic single cell suspen-
sions were prepared by incubation with 400 U/ml collagenase  d at 37 ° C for 
30 min. After blocking Fc receptors using culture supernatant of 2.4G2 hy-
bridoma, the cells were stained with the indicated fl uorochrome-conjugated 
antibodies. We used a FACS Caliber instrument (BD), and analyzed fl ow cy-
tometric data with FlowJo software (Tree Star, Inc). 
 En face immunostaining and confocal microscopic analysis.  The 
aorta was perfused with 4% ice-cold paraformaldehyde in PBS via the left 
ventricle. After removing perivascular tissues, the segments of aortic sinus, 
aortic arch, and thoracic aorta were opened longitudinally and further fi xed in 
4% paraformaldehyde at 4 ° C for 30 min. After permeabilization using 0.2% 
Triton X-100, staining for CD11c, MHC II, and CD31 was performed using 
the Tyramide amplifi cation (TSA) kit (Invitrogen) according to the manufac-
turer ’ s protocol. To stain DC processes exposed to the vessel lumen, we omit-
ted the permeabilization of aortic segments with 0.2% Triton X-100. After 
staining, the aortic segments were mounted on glass slides with aqueous 
mounting medium. For in vivo CD11c staining, 15  μ g of biotinylated anti-
CD11c antibody was injected i.v. to CD11c-EYFP mice. After 3 h, the aorta 
was collected and incubated with 3% H 2 O 2 and TSA blocking buff er to re-
move endogenous peroxidase activity and block nonspecifi c antibody bind-
ing. Then the aorta was incubated with horseradish peroxidase – conjugated 
streptavidin for 1 h. After washing with PBS, the stained CD11c was visual-
ized using Alexa Fluor 555 tyramide. The confocal images of en face immuno-
staining were obtained with an inverted laser scanning microscope (510 Meta; 
Carl Zeiss, Inc.). All confocal sections were taken along the Z axis to visualize 
all processes from each DC. We also used the Imaris program (Bitplane) to 
perform three-dimensional reconstitution of the confocal images taken along 
the Z axis. 
 Presentation to OVA-specifi c TCR transgenic T cells.  In the case of 
CD11c-EYFP transgenic mice, the EYFP-positive and -negative cells were 
isolated from single cell suspensions of aorta and spleen using FACS sorting 
(FACS Vantage; BD). For nontransgenic B6 mice, aortic CD11c + and CD11c    
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cells were isolated using anti-CD11c magnetic beads (Miltenyi Biotech). 
CD4 + or CD8 + T cells were isolated from OT-I or OT-II mice (provided by 
J. Kuroiwa, The Rockefeller University, New York, NY) by excluding B220 + , 
F4/80 + , NK1.1 + , I-A b+ , and CD4 + (for OT-I) or CD8 + (for OT-II) cells using 
anti – rat IgG Dynabeads (Invitrogen). T cells were added to round bottom mi-
crotest wells at 30,000/well and mixed with isolated DCs at a DC/T cell ratio 
of 1:6. OVA protein and peptide were added to the culture at the indicated 
concentrations. After 4 d for OT-I or 5 d for OT-II, the proliferation of OT-I 
or OT-II cells was evaluated by CFSE dilution on the FACS. For DC fi xation, 
isolated DCs were incubated with 2% paraformaldehyde for 10 min at room 
temperature. After washing with PBS, the fi xed DCs were incubated in serum-
free RPMI1640 medium containing 0.5M  dl -lysine for 30 min. After washing 
twice with culture medium, the fi xed DCs were mixed with T cells and incu-
bated at the indicated concentration of peptide or protein. 
 Cross-presentation to malaria CSP-specifi c TCR transgenic T cells. 
 The CSP of  Plasmodium yoelii – specifi c TCR transgenic mice and the plasmid 
for the CSP expression have been previously described ( 37, 38 ). After induc-
tion of CSP expression in  Escherichia coli (BL-21), His-tagged CSP was isolated 
using Ni-NTA and then subjected to FPLC to obtain high protein purity 
without contaminating endotoxin. The protein buff er was then exchanged 
for serum-free RPMI1640 medium using a Centricon (Millipore). Aortic and 
splenic CD11c high CD3    CD19    DX5    DCs from C × B6 F 1 mice were iso-
lated by FACS sorting. The CSP-specifi c CFSE-labeled CD8 + T cells were 
negatively selected by excluding B220 + , F4/80 + , NK1.1 + , I-A d+ , and CD4 + 
cells using anti – rat IgG Dynabeads (Invitrogen) and mixed with isolated DCs 
and antigens including protein and peptide for 4 d as indicated in the results. 
 In vivo OVA presentation.  5 mg OVA was injected i.v. to CD11c-EYFP 
mice. After 20 h, the aortic segments were dissociated by enzyme mixture 
(450 U/ml collagenase I, 125 U/ml collagenase XI, 60 U/ml hyaluronidase, 
and 60 U/ml DNase), and the EYFP + and EYFP    cells were isolated by FACS 
sorting. The isolated cells were mixed with OT-1 cells at ratio of 1:3. After 
3 d, T cell proliferation was analyzed by CFSE dilution. 
 Online supplemental material.  Fig. S1 shows the comparison of cell sur-
face markers of aortic and splenic endogenous CD11c + DCs. Fig. S2 demon-
strates that OT-I cells can respond to relatively low doses of OVA presented 
by splenic DCs when compared with mouse malaria CSP-specifi c TCR trans-
genic CD8 + T cells. Fig. S3 indicates that the OVA and CSP preparations were 
not contaminated with active peptides. Fig. S4 shows the importance of DC 
dose and culture time for cross-presentation. Video 1 shows the subintimal lo-
calization of aortic DCs. Video 2 shows that some DCs infrequently have den-
dritic process extending to aortic lumen. Video 3 shows that the DC processes 
are localized on the surface of elastic lamina. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20082129/DC1. 
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